Antibody-Mediated Rejection: Pathogenesis, Prevention, Treatment, and Outcomes
Antibody-mediated rejection (AMR) is a major cause of late kidney transplant failure. It is important to have an understanding of human-leukocyte antigen (HLA) typing including well-designed studies to determine anti-MHC-class-I-related chain A (MICA) and antibody rejection pathogenesis. This can a...
Saved in:
Main Authors: | Olivia R. Blume, Sarah E. Yost, Bruce Kaplan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Journal of Transplantation |
Online Access: | http://dx.doi.org/10.1155/2012/201754 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antibody-Mediated Rejection in Kidney Transplantation: A Review
by: Chethan Puttarajappa, et al.
Published: (2012-01-01) -
Role of microvascular pericyte dysfunction in antibody-mediated rejection following kidney transplantation
by: Jie Xu, et al.
Published: (2025-12-01) -
Antibody-Mediated Rejection and Sponge Effect in a Redo Lung Transplant Recipient
by: Ashwini Arjuna, et al.
Published: (2021-01-01) -
Laparoscopic Splenectomy to Salvage Renal Transplants from Severe Acute Antibody-Mediated Rejection
by: Michael Latzko, et al.
Published: (2012-01-01) -
Late and Chronic Antibody-Mediated Rejection: Main Barrier to Long Term Graft Survival
by: Qiquan Sun, et al.
Published: (2013-01-01)